Align Technology (NASDAQ:ALGN – Get Free Report) is scheduled to be posting its quarterly earnings results after the market closes on Wednesday, April 24th. Analysts expect Align Technology to post earnings of $1.98 per share for the quarter. Align Technology has set its Q1 2024 guidance at EPS.Individual interested in registering for the company’s earnings conference call can do so using this link.
Align Technology (NASDAQ:ALGN – Get Free Report) last issued its quarterly earnings data on Wednesday, January 31st. The medical equipment provider reported $1.91 EPS for the quarter, topping analysts’ consensus estimates of $1.78 by $0.13. Align Technology had a net margin of 11.52% and a return on equity of 13.88%. The firm had revenue of $956.73 million for the quarter, compared to analyst estimates of $928.57 million. On average, analysts expect Align Technology to post $8 EPS for the current fiscal year and $9 EPS for the next fiscal year.
Align Technology Trading Up 0.6 %
Shares of NASDAQ ALGN opened at $300.82 on Tuesday. The firm has a market capitalization of $22.64 billion, a PE ratio of 51.69, a price-to-earnings-growth ratio of 5.35 and a beta of 1.65. Align Technology has a 1 year low of $176.34 and a 1 year high of $413.20. The firm’s 50-day moving average is $312.75 and its 200-day moving average is $270.03.
Insider Buying and Selling
Wall Street Analyst Weigh In
ALGN has been the topic of several recent research reports. UBS Group raised their target price on shares of Align Technology from $280.00 to $320.00 and gave the company a “neutral” rating in a research note on Monday, April 15th. SVB Leerink initiated coverage on shares of Align Technology in a research note on Monday, February 26th. They issued a “market perform” rating and a $310.00 target price on the stock. Stifel Nicolaus raised their target price on shares of Align Technology from $350.00 to $400.00 and gave the company a “buy” rating in a research note on Thursday, April 18th. Leerink Partnrs reaffirmed a “market perform” rating on shares of Align Technology in a research note on Monday, February 26th. Finally, Piper Sandler raised their target price on shares of Align Technology from $335.00 to $355.00 and gave the company an “overweight” rating in a research note on Thursday, March 14th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and six have given a buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $344.45.
Get Our Latest Research Report on Align Technology
About Align Technology
Align Technology, Inc designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth.
Recommended Stories
- Five stocks we like better than Align Technology
- Canada Bond Market Holiday: How to Invest and Trade
- It’s Time to Buy Into the Super Micro Computer Stock Implosion
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- Merger or Not, Albertson’s Companies is a Good Buy
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- 3 Cheap Stocks That Shouldn’t Be So
Receive News & Ratings for Align Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Align Technology and related companies with MarketBeat.com's FREE daily email newsletter.